We are live on ! Find out more
CWM

Catamount Wealth Management Portfolio holdings

AUM $176M
1-Year Est. Return 15.01%
This Fund
S&P 500
This Quarter Est. Return
+5.68%
1 Year Est. Return
+15.01%
3 Year Est. Return
+70.68%
5 Year Est. Return
10 Year Est. Return
AUM
$164M
AUM Growth
+$18.3M
Cap. Flow
+$11.8M
Cap. Flow %
7.16%
Top 10 Hldgs %
63.05%
Holding
207
New
33
Increased
21
Reduced
30
Closed
31

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$4.83M
2
IBB icon
iShares Biotechnology ETF
IBB
+$3.62M
3
ATVI
Activision Blizzard
ATVI
+$2.94M
4
CRM icon
Salesforce
CRM
+$2.21M
5
CSX icon
CSX Corp
CSX
+$2.2M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$5.32M
2
NVDA icon
NVIDIA
NVDA
+$2.82M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$675K
4
IBM icon
IBM
IBM
+$277K
5
USB icon
US Bancorp
USB
+$260K

Sector Composition

Rank Sector Weight
1 Communication Services 29.62%
2 Financials 19.71%
3 Consumer Discretionary 12.86%
4 Industrials 5.31%
5 Technology 3.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLPI
201
DELISTED
UBS E-TRACS Alerian MLP Infrastructure ETN
MLPI
-1,288
Closed -$38K
TIME
202
DELISTED
Time Inc.
TIME
$0 ﹤0.01%
3
RAI
203
DELISTED
Reynolds American Inc
RAI
-132
Closed -$8K
YHOO
204
DELISTED
Yahoo Inc
YHOO
-25
Closed -$1K
INVT
205
DELISTED
Inventergy Global, Inc.
INVT
-1
Closed
FTR
206
DELISTED
Frontier Communications Corp.
FTR
$0 ﹤0.01%
15
WES
207
DELISTED
Western Gas Partners Lp
WES
-1,000
Closed -$60K

Similar funds

Catamount Wealth Management's Q2 2017 Portfolio in Review

As of Q2 2017, Catamount Wealth Management held 207 positions worth $164M, up 13% from $146M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Catamount Wealth Management deployed $11.8M of net new capital in Q2 2017, opening 33 new positions and adding to 21 existing holdings. Its largest new stake was iShares Biotechnology ETF: 36,720 shares worth $3.79M.

By sector, the portfolio is most concentrated in Communication Services at 30% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Celgene Corp, an estimated $5.32M trimmed.

  • Catamount Wealth Management's largest Q2 2017 buy was iShares Biotechnology ETF: 36,720 shares worth $3.79M.
  • Catamount Wealth Management added most to Alibaba in Q2 2017, an estimated $4.83M increase.
  • Catamount Wealth Management's biggest Q2 2017 reduction was Celgene Corp, cutting an estimated $5.32M.
  • Catamount Wealth Management fully exited Walmart Inc in Q2 2017, selling an estimated $231K.
  • Catamount Wealth Management's ten largest holdings make up 63% of its $164M portfolio in Q2 2017.
  • Catamount Wealth Management opened 33 new positions and closed 31 in Q2 2017.
  • Catamount Wealth Management's portfolio value rose 13% quarter-over-quarter to $164M.

Based on Catamount Wealth Management's 13F filing for Q2 2017, filed 4 Aug 2017.